Telbivudine is not recommended for people with chronic hepatitis B. Healthcare professionals should not stop prescribing telbivudine for people who were already taking it when the guidance was issued. These patients should be able to carry on taking telbivudine until they and their healthcareprofessionals decide that it is the right time to stop treatment.

We will consult on our review plans for this guidance in February 2009.

  • National Institute for Health and Care Excellence (NICE) accreditation logo